United States · FDA National Drug Code directory
hydroxyzine pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51655-847_4973e097-062d-29f5-e063-6294a90ae952
- Product NDC
- 51655-847
- Form
- CAPSULE
- Composition / generic term
- hydroxyzine pamoate
- Labeler
- Northwind Health Company, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230410
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROXYZINE PAMOATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 CAPSULE in 1 BOTTLE, PLASTIC (51655-847-20) · 51655-847-20
- 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-847-52) · 51655-847-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →